Advertisement
Canada markets open in 6 hours 46 minutes
  • S&P/TSX

    21,714.54
    -297.08 (-1.35%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CAD/USD

    0.7258
    -0.0003 (-0.04%)
     
  • CRUDE OIL

    81.09
    -0.84 (-1.03%)
     
  • Bitcoin CAD

    82,302.78
    -5,069.12 (-5.80%)
     
  • CMC Crypto 200

    1,279.33
    -59.74 (-4.46%)
     
  • GOLD FUTURES

    2,300.00
    -2.90 (-0.13%)
     
  • RUSSELL 2000

    1,973.91
    -42.12 (-2.09%)
     
  • 10-Yr Bond

    4.6860
    +0.0720 (+1.56%)
     
  • NASDAQ futures

    17,479.50
    -91.75 (-0.52%)
     
  • VOLATILITY

    15.65
    +0.98 (+6.68%)
     
  • FTSE

    8,144.13
    -2.90 (-0.04%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • CAD/EUR

    0.6809
    +0.0007 (+0.10%)
     

Oblong Announces Financial Results for Fourth Quarter 2023 and Provides Business Update

DENVER, March 19, 2024--(BUSINESS WIRE)--Oblong, Inc. (Nasdaq: OBLG) ("Oblong" or the "Company"), an innovator in collaboration solutions, today reported financial results for the fourth quarter and fiscal year ending December 31, 2023, and provided updates on the Company’s business and strategy.

During 2023, the Company diligently optimized its operations, streamlined expenditures, and strengthened Oblong’s balance sheet to position itself as a lean and agile innovator in the tech landscape. Oblong raised $5.9 million in funding in 2023 that we believe provides the Company with ample liquidity and a clear runway through mid-2025. This strategic financing underscores the confidence of Oblong’s investors in the Company’s vision and long-term strategy.

"Our strategy for growth and enhancing shareholder value is twofold. We aim to grow organically by expanding our market presence while actively seeking inorganic growth opportunities through strategic partnerships or acquisitions," said Peter Holst, CEO of Oblong. "Our exploration of strategic alternatives is diverse, encompassing the consideration of a range of transformative actions. These include the possibility of a business combination; a reverse merger; or outright sale of the company. Each option is being carefully evaluated to ensure it aligns with our overarching goal of sustainable growth and value creation. Specifically, we are interested in early-stage technology companies creating transformative approaches to leveraging technology for the betterment of human life. These companies may complement our existing offerings but could also open new avenues for expansion by tapping into significant market opportunities. In our quest to find the right partners, we are particularly focused on ventures that have demonstrated their ability to innovate and capture early-stage interest of their target markets, indicating a clear path to scalability and a substantial market presence."

Fourth Quarter 2023 Financial Results

  • As of December 31, 2023, the Company had $6.0 million of cash and cash equivalents and no debt.

ADVERTISEMENT
  • Total revenue was $0.9 million for the fourth quarter of 2023 versus $1.4 million for the fourth quarter of 2022.

  • Net loss of $1.2 million for the fourth quarter of 2023, compared to a net loss of $1.2 million for the fourth quarter of 2022.

  • Adjusted EBITDA ("AEBITDA") loss of $0.9 million for the fourth quarter of 2023, compared to an AEBITDA loss of $1.2 million for the fourth quarter of 2022. AEBITDA loss is a non-GAAP financial measure. See "Non-GAAP Financial Information" below for additional information regarding this non-GAAP financial measure, and "GAAP to Non-GAAP Reconciliation" for a reconciliation of this non-GAAP financial measure to net loss.

Non-GAAP Financial Information

Adjusted EBITDA ("AEBITDA") loss, a non-GAAP financial measure, is defined as net loss before depreciation and amortization, stock-based compensation and expense, impairment charges, casualty loss, severance, income tax expense (benefit), and interest and other income, net. AEBITDA loss is not intended to replace operating loss, net loss, cash flow or other measures of financial performance reported in accordance with generally accepted accounting principles (GAAP). Rather, AEBITDA loss is an important measure used by management to assess the operating performance of the Company and to compare such performance between periods. AEBITDA loss as defined here may not be comparable to similarly titled measures reported by other companies due to differences in accounting policies. Therefore, AEBITDA loss should be considered in conjunction with net loss and other performance measures prepared in accordance with GAAP, such as operating loss or cash flow used in operating activities, and should not be considered in isolation or as a substitute for GAAP measures, such as net loss, operating loss or any other GAAP measure of liquidity or financial performance. A GAAP to non-GAAP reconciliation of net loss to AEBITDA loss is shown under "GAAP to Non-GAAP Reconciliation" later in this release.

About Oblong, Inc.

Oblong (Nasdaq:OBLG) provides innovative and patented technologies that change the way people work, create, and communicate. Oblong’s flagship product Mezzanine™ is a remote meeting technology platform that offers simultaneous content sharing to achieve situational awareness for both in-room and remote collaborators. Oblong supplies Mezzanine systems to Fortune 500 and enterprise customers. For more information, visit www.oblong.com and Oblong’s Twitter and Facebook pages.

Forward looking and cautionary statements

This press release and any oral statements made regarding the subject of this release contain forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, that address activities that Oblong assumes, plans, expects, believes, intends, projects, estimates or anticipates (and other similar expressions) will, should or may occur in the future are forward-looking statements. Oblong’s actual results may differ materially from its expectations, estimates and projections, and consequently you should not rely on these forward-looking statements as predictions of future events. Without limiting the generality of the foregoing, forward-looking statements contained in this press release include statements relating to (i) the Company’s exploration of strategic alternatives, including the Company’s goal to forge partnerships with select early-stage technology companies and the mission to deliver innovative technology solutions, and (ii) the Company’s liquidity and operating expense projections. There can be no assurance that the strategic review being undertaken will result in a merger, sale or other business combination involving the Company. The forward-looking statements are based on management’s current belief, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties, including the volatility of market price for our securities, that may cause actual results in future periods to differ materially from such statements. A list and description of these and other risk factors can be found in the Company’s Annual Report on Form 10-K for the year ending December 31, 2023 and in other filings made by the Company with the SEC from time to time. Any of these factors could cause Oblong’s actual results and plans to differ materially from those in the forward-looking statements. Therefore, the Company can give no assurance that its future results will be as estimated. The Company does not intend to, and disclaims any obligation to, correct, update, or revise any information contained herein.

OBLONG, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

($ in thousands, except par value and stated value)

December 31, 2023

December 31, 2022

ASSETS

Current assets:

Cash and cash equivalents

$

5,990

$

3,085

Accounts receivable, net

424

415

Inventory, net

239

723

Prepaid expenses and other current assets

243

649

Total current assets

6,896

4,872

Property and equipment, net

3

Intangibles, net

604

Operating lease, right-of-use assets

17

142

Other assets

12

40

Total assets

$

6,925

$

5,661

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

211

184

Accrued expenses and other current liabilities

1,038

1,074

Current portion of deferred revenue

132

436

Current portion of operating lease liabilities

17

219

Total current liabilities

1,398

1,913

Long-term liabilities:

Deferred revenue, net of current portion

26

114

Operating lease liabilities, net of current portion

17

Total long-term liabilities

26

131

Total liabilities

1,424

2,044

Commitments and contingencies

Stockholders’ equity:

Preferred stock Series F, convertible; $.0001 par value; $2,064,063 stated value; 42,000 shares authorized, 1,930 and zero shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively

Common stock, $.0001 par value; 150,000,000 shares authorized; 16,692,000 shares issued and 16,685,000 shares outstanding at December 31, 2023 and 2,071,000 shares issued and 2,063,000 outstanding at December 31, 2022

2

Treasury stock, 8,000 common shares at December 31, 2023 and 2022

(181

)

(181

)

Additional paid-in capital

233,911

227,645

Accumulated deficit

(228,231

)

(223,847

)

Total stockholders’ equity

5,501

3,617

Total liabilities and stockholders’ equity

6,925

5,661

OBLONG, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

($ in thousands) (Unaudited)

Three Months Ended

Year Ended

December 31,

December 31,

2023

2022

2023

2022

Revenue

$

944

$

1,426

$

3,810

$

5,476

Cost of revenue (exclusive of depreciation and amortization and casualty loss)

655

1,130

2,899

3,930

Gross profit

289

296

911

1,546

Operating expenses (gains):

Research and development

4

65

20

1,699

Sales and marketing

68

270

309

1,431

General and administrative

1,147

1,174

4,870

5,278

Impairment charges

260

25

262

12,740

Casualty (gain) loss, net

(50

)

(400

)

483

Depreciation and amortization

86

85

345

1,903

Total operating expenses

1,565

1,569

5,406

23,534

Loss from operations

(1,276

)

(1,273

)

(4,495

)

(21,988

)

Interest and other income, net

(44

)

(41

)

(138

)

(40

)

Loss before income taxes

(1,232

)

(1,232

)

(4,357

)

(21,948

)

Income tax expense (benefit)

(11

)

(15

)

27

(7

)

Net loss

$

(1,221

)

$

(1,217

)

$

(4,384

)

$

(21,941

)

GAAP to Non-GAAP Reconciliation:

Three Months Ended

Year Ended

December 31,

December 31,

2023

2022

2023

2022

Net loss

$

(1,221

)

$

(1,217

)

$

(4,384

)

$

(21,941

)

Depreciation and amortization

86

85

345

1,903

Interest and other income, net

(44

)

(41

)

(138

)

(40

)

Income tax (benefit) expense

(11

)

(15

)

27

(7

)

Impairment charges

260

25

262

12,740

Casualty loss (gain)

(50

)

(400

)

483

Severance

294

Stock-based compensation and expense

31

31

504

61

Adjusted EBITDA Loss

$

(899

)

$

(1,182

)

$

(3,784

)

$

(6,507

)

View source version on businesswire.com: https://www.businesswire.com/news/home/20240319264133/en/

Contacts

Investor Relations Contact
David Clark
investors@oblong.com
(213) 683-8863 ext. 5